India could cripple the United States by limiting its diabetes medications exports to Washington.

[Mask]

North America: A Key Market for Indian Pharmaceuticals​

The U.S., at the heart of North America, is a key market for Indian pharma exports. Indian firms have made a significant impact by providing affordable medicines and improving healthcare.

• The United States is India's largest pharmaceutical export partner.
• In 2022, India had a 47% share of the U.S. generic prescription market.
• With 6,316 US FDA approvals as of April 2023, Indian companies are in the lead.
• Between 2013 and 2022, Indian medicines saved the U.S. healthcare system $1.3 trillion.

Understanding the North American Pharmaceutical Market​

One of the biggest drug markets in the world is in North America. The market will reach $658.10 billion in 2024, driven by oncology drugs and others.

• Market Size: 2024 North America's pharmaceutical market will reach $658.10 billion. The industry is healthy and poised for growth.
• Oncology Drug Dominance: Oncology drugs are the largest drug seg

 

[Mask]

Major Pharmaceutical Products Exported to North America​

Pharmaceutical exports play a vital role in meeting North America’s healthcare needs. In 2023, the U.S. imported pharmaceutical products worth $177 billion. Some of the key items include:

• Drug formulations and biologics
• Big amounts of drugs and drug compounds
• Ayush and herbal medicines
• Surgical and general medications
• Diuretics and antidiuretics
• Pro-kinetics and gut relaxants

Regulatory Compliance: A Key to Success in North America​

In North America, especially the U.S., pharma firms must follow rules to succeed. The U.S. FDA ensures products meet strict guidelines before market entry. Manufacturers must register drugs with the FDA through different applications, such as NDA, ANDA, and BLA. New firms must understand FDA rules and submit key documents to gain approval. These complex rules challenge startups trying to enter the market. Mastering these rules is essential for pharmaceutical companies to thrive in North America.

 

[Mask]

Challenges Faced by Indian Pharma Exporters in North America​

Indian pharmaceutical exporters face several hurdles when entering the North American market. Challenges cause delays, cost more, and slow approval. Here are some key issues:

• Regulatory Compliance

Navigating complex U.S. FDA rules for drug approvals can take time and effort. It takes time to meet their strict product standards.

• Market Competition

North America has a competitive pharmaceutical market. It’s tough for new exporters to gain market share due to global players.

• Logistics and Shipping

A constant challenge is ensuring timely deliveries. It involves customs clearance, international shipping, and maintaining product quality.

• Logistical and Supply Chain Challenges

Maintaining a cold chain for certain pharmaceuticals is challenging, adding to transportation costs and risks. Delays at ports due to customs inspections or documentation issues can disrupt supply timelines.

• Evolving Healthcare Policies

Changes in healthcare reimbursement policies, such as pricing caps on generics, can reduce profitability. The introduction of stringent pricing mechanisms like Medicare reform further complicates market dynamics.